JP2019505531A5 - - Google Patents

Download PDF

Info

Publication number
JP2019505531A5
JP2019505531A5 JP2018540720A JP2018540720A JP2019505531A5 JP 2019505531 A5 JP2019505531 A5 JP 2019505531A5 JP 2018540720 A JP2018540720 A JP 2018540720A JP 2018540720 A JP2018540720 A JP 2018540720A JP 2019505531 A5 JP2019505531 A5 JP 2019505531A5
Authority
JP
Japan
Prior art keywords
formula
compound
acid
sodium
potassium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018540720A
Other languages
English (en)
Japanese (ja)
Other versions
JP6877449B2 (ja
JP2019505531A (ja
Filing date
Publication date
Priority claimed from CN201610082028.3A external-priority patent/CN107043378A/zh
Application filed filed Critical
Publication of JP2019505531A publication Critical patent/JP2019505531A/ja
Publication of JP2019505531A5 publication Critical patent/JP2019505531A5/ja
Application granted granted Critical
Publication of JP6877449B2 publication Critical patent/JP6877449B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018540720A 2016-02-05 2017-02-04 ピロロ[3,2−d]ピリミジン化合物を調製するための方法、及びそれらの中間体 Active JP6877449B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201610082028.3 2016-02-05
CN201610082028.3A CN107043378A (zh) 2016-02-05 2016-02-05 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体
PCT/CN2017/072893 WO2017133686A1 (zh) 2016-02-05 2017-02-04 一种吡咯并[3,2-d]嘧啶类化合物的制备方法及其中间体

Publications (3)

Publication Number Publication Date
JP2019505531A JP2019505531A (ja) 2019-02-28
JP2019505531A5 true JP2019505531A5 (cg-RX-API-DMAC10.html) 2020-02-27
JP6877449B2 JP6877449B2 (ja) 2021-05-26

Family

ID=59500148

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018540720A Active JP6877449B2 (ja) 2016-02-05 2017-02-04 ピロロ[3,2−d]ピリミジン化合物を調製するための方法、及びそれらの中間体

Country Status (28)

Country Link
US (2) US10654856B2 (cg-RX-API-DMAC10.html)
EP (1) EP3412673B1 (cg-RX-API-DMAC10.html)
JP (1) JP6877449B2 (cg-RX-API-DMAC10.html)
KR (1) KR102371500B1 (cg-RX-API-DMAC10.html)
CN (2) CN107043378A (cg-RX-API-DMAC10.html)
AR (1) AR107549A1 (cg-RX-API-DMAC10.html)
AU (1) AU2017214134B2 (cg-RX-API-DMAC10.html)
BR (1) BR112018015879B1 (cg-RX-API-DMAC10.html)
CA (1) CA3013520C (cg-RX-API-DMAC10.html)
CL (1) CL2018002094A1 (cg-RX-API-DMAC10.html)
DK (1) DK3412673T3 (cg-RX-API-DMAC10.html)
EA (1) EA034581B1 (cg-RX-API-DMAC10.html)
ES (1) ES2852323T3 (cg-RX-API-DMAC10.html)
HR (1) HRP20210103T1 (cg-RX-API-DMAC10.html)
HU (1) HUE053455T2 (cg-RX-API-DMAC10.html)
IL (1) IL260999B (cg-RX-API-DMAC10.html)
LT (1) LT3412673T (cg-RX-API-DMAC10.html)
MX (1) MX374298B (cg-RX-API-DMAC10.html)
MY (1) MY190551A (cg-RX-API-DMAC10.html)
NZ (1) NZ744885A (cg-RX-API-DMAC10.html)
PH (1) PH12018501642A1 (cg-RX-API-DMAC10.html)
PL (1) PL3412673T3 (cg-RX-API-DMAC10.html)
PT (1) PT3412673T (cg-RX-API-DMAC10.html)
SG (1) SG11201806685VA (cg-RX-API-DMAC10.html)
SI (1) SI3412673T1 (cg-RX-API-DMAC10.html)
TW (1) TW201728590A (cg-RX-API-DMAC10.html)
UA (1) UA124100C2 (cg-RX-API-DMAC10.html)
WO (1) WO2017133686A1 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9815850B2 (en) 2016-02-05 2017-11-14 Denali Therapeutics Inc. Compounds, compositions and methods
CN107043380A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
BR112021015577A2 (pt) 2019-02-08 2021-10-05 Research & Business Foundation Sungkyunkwan University Complexo-colesterol agonista do receptor toll-like 7 ou 8 e uso do mesmo
CN115666637A (zh) 2020-03-02 2023-01-31 蛋白科技先锋 基于病原体细胞壁骨架的模拟活病原体的纳米粒子及其制备方法
EP4194008A4 (en) 2020-08-04 2025-01-08 Progeneer Inc. Kinetically acting adjuvant ensemble
WO2022031021A1 (ko) 2020-08-04 2022-02-10 성균관대학교산학협력단 동력학적 제어가 가능한 아주번트를 포함하는 mrna 백신
US20230277525A1 (en) 2020-08-04 2023-09-07 Progeneer Inc Conjugate of functional drug and toll-like receptor 7 or 8 agonist of which active site is temporarily inactivated and use thereof
EP4463229A1 (en) 2022-01-12 2024-11-20 Denali Therapeutics Inc. Crystalline forms of (s)-5-benzyl-n-(5-methyl-4-oxo-2, 3,4,5- tetrahydropyrido [3,2-b] [l,4]oxazepin-3-yl)-4h-l,2,4-triazole-3-carboxamide
WO2025110816A1 (ko) 2023-11-23 2025-05-30 프로지니어 주식회사 암의 치료를 위한 활성화 부위가 일시적으로 비활성화된 톨-유사 수용체 7 또는 8 작용자와 항암 치료의 병용요법

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009082247A1 (en) 2007-12-21 2009-07-02 Industrial Research Limited Process for preparing immucillins having a methylene link
UY32306A (es) 2008-12-09 2010-07-30 Gilead Sciences Inc Derivados de pteridinona y pirimidinodiazepinona y composiciones farmacéuticas que modulan en forma selectiva los receptores tipo toll, métodos y usos
MX386924B (es) * 2012-10-10 2025-03-19 Janssen Sciences Ireland Uc Derivados pirrolo[3,2-d]pirimidínicos para el tratamiento de infecciones víricas y otras enfermedades.
JP6216387B2 (ja) * 2012-11-20 2017-10-18 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーGlaxoSmithKline LLC 新規化合物
SMT201700378T1 (it) * 2012-11-20 2017-09-07 Glaxosmithkline Llc Nuovi composti
WO2015168269A1 (en) * 2014-05-01 2015-11-05 Novartis Ag Compounds and compositions as toll-like receptor 7 agonists
CN112898308B (zh) 2014-08-15 2026-08-07 正大天晴药业集团股份有限公司 作为tlr7激动剂的吡咯并嘧啶化合物
CN105367576A (zh) 2014-08-15 2016-03-02 正大天晴药业集团股份有限公司 作为tlr7激动剂的吡咯并嘧啶化合物
KR102112192B1 (ko) * 2015-11-05 2020-05-19 치아타이 티안큉 파마수티컬 그룹 주식회사 Tlr7 효능제로서의 7-(티아졸-5-일)피롤로피리미딘 화합물
CN107043377A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的三氟乙酸盐、晶型b及其制备方法、药物组合物和用途
CN107043380A (zh) * 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的马来酸盐、其晶型c、晶型d、晶型e、制备方法和用途
CN107043379A (zh) 2016-02-05 2017-08-15 正大天晴药业集团股份有限公司 一种tlr7激动剂的晶型a、其制备方法和医药用途

Similar Documents

Publication Publication Date Title
JP2022133462A5 (cg-RX-API-DMAC10.html)
JP2016512824A5 (cg-RX-API-DMAC10.html)
HRP20210103T1 (hr) Postupak za proizvodnju spoja pirol0[3,2-d]pirimidina, kao i odgovarajućih intermedijera
JP2016512823A5 (cg-RX-API-DMAC10.html)
JP2011046703A (ja) ニトリル化合物、カルボン酸化合物又はカルボン酸エステル化合物の製法
JP2008505171A5 (cg-RX-API-DMAC10.html)
JP2013538849A5 (cg-RX-API-DMAC10.html)
JP2010536713A5 (cg-RX-API-DMAC10.html)
JP2014518240A5 (cg-RX-API-DMAC10.html)
JP2006312632A (ja) テルミサルタンの調製方法
JP2021504440A5 (cg-RX-API-DMAC10.html)
JP2010511649A5 (cg-RX-API-DMAC10.html)
WO2018032586A1 (zh) 一种3-(二氟甲基)-1-甲基-1h-吡唑-4-羧酸的合成方法及其中间体
JP7252978B2 (ja) 2-(1-(tert-ブトキシカルボニル)ピペリジン-4-イル)安息香酸を調製するためのプロセス
JP7232618B2 (ja) アコチアミドの改善された製造方法
JP6611942B2 (ja) オキサゾリジノン誘導体の中間体の製造方法{Preparation method of intermediate for oxazolidinone derivative}
CN113336792A (zh) 一种环状膦酸酯化合物的制备方法
EP1905770A1 (en) A process for the preparation of phenyltetrazole compounds
JP2008533189A (ja) 1−置換1H−イミダゾ[4,5−c]キノリン−4−アミン化合物及びそれらのための中間体を製造するための方法
JP5796836B2 (ja) ピタバスタチンまたはその塩の中間体の製造方法
TW201041855A (en) New process for preparing
JP2015535210A5 (cg-RX-API-DMAC10.html)
CZ295949B6 (cs) Způsob výroby fexofenadinu
JP2013136561A (ja) 2,6−ジエチル−4−メチルフェニル酢酸の製造方法
JP5702956B2 (ja) 芳香族トリカルボン酸